![Phase II Study of Carfilzomib, Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma | Research To Practice Phase II Study of Carfilzomib, Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCHEM2013/1/2/Slide01.jpg)
Phase II Study of Carfilzomib, Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma | Research To Practice
![Inside the marrow: exploring the immune microenvironment of multiple myeloma with single cell RNA-sequencing - 10x Genomics Inside the marrow: exploring the immune microenvironment of multiple myeloma with single cell RNA-sequencing - 10x Genomics](https://cdn.10xgenomics.com/image/upload/dpr_2.0,f_auto,q_auto/v1612459418/blog/multiple_myeloma_cells.jpg)
Inside the marrow: exploring the immune microenvironment of multiple myeloma with single cell RNA-sequencing - 10x Genomics
![STAT: Perlmutter Cancer Center Hematologist–Oncologist Discusses Promising New Treatment for Multiple Myeloma | NYU Langone News STAT: Perlmutter Cancer Center Hematologist–Oncologist Discusses Promising New Treatment for Multiple Myeloma | NYU Langone News](https://nyulangone.org/news/sites/default/files/styles/hero/public/2022-12/inthemedia-pcc-promising-new-treatment-multiple-myeloma.jpg?h=1904b0a8&itok=20CArQNT)